Product
Capsaicin 0.04% Topical System
1 clinical trial
1 indication
Indication
Post Surgical Neuropathic PainClinical trial
An Interventional, Phase III, Double-blind, Randomized, Controlled, Parallel-group, Multi-site, Clinical Trial Evaluating the Efficacy and Safety of Qutenza® in Subjects With Post-surgical Neuropathic PainStatus: Recruiting, Estimated PCD: 2024-10-01